Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study. (Q41664463)
Jump to navigation
Jump to search
scientific article published on 18 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study. |
scientific article published on 18 December 2014 |
Statements
Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study (English)
Tsutomu Yoshikawa
Hiroshi Okamoto
Akira Kitabatake
Masatsugu Hori
Japanese Chronic Heart Failure Study Investigators
18 December 2014